Clinical Trials on Contrast-induced Acute Kidney Injury (CI-AKI) Following Coronary Angiogram (CI-AKI) in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- kıvan çevik kaya
- Diabetes Research Institute, Munich, Germany.
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Department of Orthopedics, Norrköping
- Phoenix VA Health Care System
- Rivus Pharmaceuticals, Inc.
- Retina Foundation of Canada
- Dr. Khaled Ahmed Yassen
- Canadian Glycomics Network (GlycoNet)
- Merve Şeker
- South Texas Health System McAllen
- Jinxiang County People's Hospital
- Critical Care Pharmacotherapy Trials Network
- Bettina Eiger
- Pearl Network
- EXCELYA Bordeaux
- Alcohol Education and rehabilitation Fund
- EndoTheia
- View Full List
Medical Conditions
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Myocardial Haemorrhage
- Tumor Cell, Circulating
- Secondary Pulmonary Arterial Hypertension
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Morton's Neuroma
- Deep Neck Space Infections
- Fluorescein Angiography
- Racial Bias
- Dystonic Disorders
- Presence / Absence of EBV
- Malignant Pelvic Neoplasm
- Newborn Infants
- Poststroke Fatigue
- Ruptured Achilles Tendon
- Acute Rotator Cuff Tear Related to Trauma
- Encephalitis, Arbovirus
- Cystic Renal Disease
- View Full List
Drug Interventions
- Modified Bolus 5-FU/LV with Irinotecan
- Cetuximab
- PCO371
- Vinorelbine tartrate
- Visanne (Dienogest, BAY86-5258)
- Sipuleucel-T
- Tenofovir
- Amisulpride Oral Tablet
- Ketamine 0.3 mg/kg at anesthesia induction
- Trastuzumab in combination with SubQ GM-CSF
- Nicoderm C-Q Transdermal Product
- Follitropin beta liquid formulation
- Tranexamic acid
- Anastrozole
- Sodium Nitroprusside
- Percutaneous sirolimus
- 30 mg CVL-231 as slow-release MR formulation
- 5.0g SRT501
- Granulocyte colony-stimulating factor
- 6-Mercaptopurine
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Colombia
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Finland
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Israel
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Uzbekistan
- CRO list by country